These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11552016)

  • 1. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.
    Fazekas F; Strasser-Fuchs S; Kollegger H; Berger T; Kristoferitsch W; Schmidt H; Enzinger C; Schiefermeier M; Schwarz C; Kornek B; Reindl M; Huber K; Grass R; Wimmer G; Vass K; Pfeiffer KH; Hartung HP; Schmidt R
    Neurology; 2001 Sep; 57(5):853-7. PubMed ID: 11552016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.
    Enzinger C; Ropele S; Strasser-Fuchs S; Kapeller P; Schmidt H; Poltrum B; Schmidt R; Hartung HP; Fazekas F
    Arch Neurol; 2003 Jan; 60(1):65-70. PubMed ID: 12533090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.
    Pinholt M; Frederiksen JL; Andersen PS; Christiansen M
    Mult Scler; 2005 Oct; 11(5):511-5. PubMed ID: 16193886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.
    Zwemmer JN; van Veen T; van Winsen L; van Kamp GJ; Barkhof F; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Jun; 10(3):272-7. PubMed ID: 15222690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
    Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotype does not influence the progression of multiple sclerosis.
    Savettieri G; Andreoli V; Bonavita S; Cittadella R; Caltagirone C; Fazio MC; Girlanda P; Le Pira F; Liguori M; Logroscino G; Lugaresi A; Nocentini U; Reggio A; Salemi G; Serra P; Tedeschi G; Toma L; Trojano M; Valentino P; Quattrone A
    J Neurol; 2003 Sep; 250(9):1094-8. PubMed ID: 14504972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate.
    Høgh P; Oturai A; Schreiber K; Blinkenberg M; Jørgensen OS; Ryder L; Paulson OB; Sørensen PS; Knudsen GM
    Mult Scler; 2000 Aug; 6(4):226-30. PubMed ID: 10962542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE genotypes and disease severity in multiple sclerosis.
    Masterman T; Zhang Z; Hellgren D; Salter H; Anvret M; Lilius L; Lannfelt L; Hillert J
    Mult Scler; 2002 Apr; 8(2):98-103. PubMed ID: 11990879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of apolipoprotein E genotypes with prognosis in multiple sclerosis.
    Tamam Y; Tasdemir N; Yalman M; Tamam B
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1122-30. PubMed ID: 22165672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.
    De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP
    Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis.
    Chapman J; Sylantiev C; Nisipeanu P; Korczyn AD
    Arch Neurol; 1999 Dec; 56(12):1484-7. PubMed ID: 10593303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
    Burwick RM; Ramsay PP; Haines JL; Hauser SL; Oksenberg JR; Pericak-Vance MA; Schmidt S; Compston A; Sawcer S; Cittadella R; Savettieri G; Quattrone A; Polman CH; Uitdehaag BM; Zwemmer JN; Hawkins CP; Ollier WE; Weatherby S; Enzinger C; Fazekas F; Schmidt H; Schmidt R; Hillert J; Masterman T; Hogh P; Niino M; Kikuchi S; Maciel P; Santos M; Rio ME; Kwiecinski H; Zakrzewska-Pniewska B; Evangelou N; Palace J; Barcellos LF
    Neurology; 2006 May; 66(9):1373-83. PubMed ID: 16682670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The absence of a relation between apolipoprotein E genotypes and the severity of multiple sclerosis in Mexican patients].
    Corona T; Guerrero-Camacho JL; Alonso-Vilatela ME; Flores-Rivera Jde J
    Rev Neurol; 2010 Jan 1-15; 50(1):19-22. PubMed ID: 20073019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association of apolipoprotein E epsilon4 genotype with faster progression or less recovery of relapses in a Spanish cohort of multiple sclerosis.
    Sedano MI; Calmarza P; Perez L; Trejo JM
    Mult Scler; 2006 Feb; 12(1):13-8. PubMed ID: 16459715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis.
    Fazekas F; Strasser-Fuchs S; Schmidt H; Enzinger C; Ropele S; Lechner A; Flooh E; Schmidt R; Hartung HP
    J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):25-8. PubMed ID: 10864599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis.
    Zakrzewska-Pniewska B; Styczynska M; Podlecka A; Samocka R; Peplonska B; Barcikowska M; Kwiecinski H
    Mult Scler; 2004 Jun; 10(3):266-71. PubMed ID: 15222689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE genotype is a major predictor of long-term progression of disability in MS.
    Chapman J; Vinokurov S; Achiron A; Karussis DM; Mitosek-Szewczyk K; Birnbaum M; Michaelson DM; Korczyn AD
    Neurology; 2001 Feb; 56(3):312-6. PubMed ID: 11171894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis.
    Weatherby SJ; Mann CL; Davies MB; Carthy D; Fryer AA; Boggild MD; Young C; Strange RC; Ollier W; Hawkins CP
    Mult Scler; 2000 Feb; 6(1):32-6. PubMed ID: 10694843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
    van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H
    Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4.
    Enzinger C; Ropele S; Smith S; Strasser-Fuchs S; Poltrum B; Schmidt H; Matthews PM; Fazekas F
    Ann Neurol; 2004 Apr; 55(4):563-9. PubMed ID: 15048896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.